Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PVCT/Capital expenditures

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Capital expenditures 2016–2018

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$30,400FY2018 · since FY2016: $6,139 → $30,400
1618
Fiscal yearValueYoY
FY2018$30,400—
FY2016$6,139—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More PVCT financial trends

PVCT RevenuePVCT Net incomePVCT Net marginPVCT Gross profitPVCT Gross marginPVCT Operating incomePVCT Operating marginPVCT Operating cash flowPVCT Free cash flowPVCT Return on equityPVCT Stock buybacksPVCT Dividends paidPVCT Total assetsPVCT Total liabilitiesPVCT Shareholders’ equityPVCT overview →